GAMMAGARD SENTIVY
Live / Applied — Fourth extension granted (statement of use) (as of 28 May 2025)
What this means for you
Not registered yet, but its 07 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97623653
- Mark type
- Stylized text
- Filed
- 07 Oct 2022
- Published for opposition
- 20 Jun 2023
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Immunoglobulin for subcutaneous and intravenous administration to humans
Owner
- Baxalta Incorporated, Bannockburn, IL, US
- Baxalta Incorporated, Bannockburn, IL, US
Prior registrations
Prosecution history
- 01 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2025 — SOU EXTENSION 4 GRANTED
- 28 May 2025 — SOU EXTENSION 4 FILED
- 28 May 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jan 2025 — SOU EXTENSION 3 GRANTED
- 31 Jan 2025 — SOU EXTENSION 3 FILED
- 31 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2024 — SOU EXTENSION 2 GRANTED
- 18 Jun 2024 — SOU EXTENSION 2 FILED